FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and concerns linear hetarene anthracenediones, containing in positions 4, 11 aminoalkylamino groups and in position 2 alkylcarboxamide group with terminal guanidine, having high selectivity of binding with G-quadruplex structures of nucleic acids, suitable for blocking tumour growth and corresponding to formula: 
, where X is independently a heteroatom (selected from O, S) or NH-group; Y denotes a heteroatom (O, S) CH2-group or a simple carbon-carbon bond; m independently equals 2 or 3, equal to number of carbon atoms of alkylene spacer.
EFFECT: obtaining linear hetarene anthracenediones.
3 cl, 2 tbl, 1 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL HETEROARENE ANTHRACENEDIONE-BASED G-QUADRUPLEX LIGANDS INHIBITING TUMOUR CELL GROWTH | 2013 |
|
RU2527459C1 |
| MULTITARGET INHIBITORS OF TUMOUR GROWTH BASED ON LINEAR HETEROARENE ANTHRACENEDIONES | 2013 |
|
RU2527273C1 |
| NEW HETEROARENANTHRACENE-2-CARBOXAMIDE DERIVATIVES INHIBITING TUMOUR GROWTH | 2016 |
|
RU2631100C1 |
| CYTOTOXIC LINEAR HETEROCYCLIC DERIVATIVES OF ANTHRACENEDIONE HAVING IN SIDE CHAIN CYCLIC DIAMINES, ACTIVE TOWARDS TUMOUR CELLS WITH MULTIDRUG RESISTANCE | 2009 |
|
RU2412166C1 |
| ANTI-TUMOR NAPHTHOINDOLE-3-CARBOXAMIDE DERIVATIVE | 2019 |
|
RU2712191C1 |
| ANTITUMOUR ANTHRAFURANDIONE AND BASED PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2554939C1 |
| PYRROLO[1,2-A]PYRAZINE-CONTAINING LIGANDS OF THE 18 KDA TRANSLOCATOR PROTEIN WITH ANXIOLYTIC ACTIVITY | 2022 |
|
RU2812083C2 |
| DERIVATIVES OF BENZODIOXOL, BENZOFURAN, DIHYDROBENZOFURAN AND BENZODIOXANE AND COMPOSITIONS COMPRISING THEREOF | 1997 |
|
RU2190609C2 |
| METHOD OF OBTAINING ANTHRA[2,3-b]FURAN-3-CARBOXYLIC ACID | 2014 |
|
RU2554937C1 |
| SEMI-SYNTHETIC DERIVATIVES OF HELIOMYCIN INHIBITING TUMOR GROWTH | 2016 |
|
RU2644780C2 |
